skin reaction to tirzepatide injection site reactions after long-term subcutaneous delivery of drisapersen: a retrospective study Allergic Reaction to Tirzepatide Injection:

Extracted data included trial identifiers (NCT number, phase, duration), baseline population characteristics (baseline BMI, diabetes status), specific intervention arms and dosages, primary and secondary metabolic outcomes, and safety parameters

Protect from light Store tirzepatide in its original packaging or in an opaque container

It is not FDA-approved and may vary in strength or purity

Stop using Wegovy and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without nausea or vomiting

Funding All the activities related to the preparation of this article have been supported by an unconditioned grant from Ipsen